Skip to content

Clinical Study on Comprehensive Nutritional Management for Gastric Cancer Patients

Clinical Study on Comprehensive Nutritional Management for Gastric Cancer Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098607
Enrollment
Unknown
Registered
2025-03-11
Start date
2024-03-25
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Control group:1.In-hospital Intervention Routine nutritional therapy was administered: ? Condition monitoring. Close observation of patients' condition changes, proper basic nursing care, timely detec
Experimental group:Nutritional Intervention Measures within and b

Sponsors

Liaoning Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with a pathological diagnosis of gastric adenocarcinoma; 2. Aged between 18 and 80 years, with the ability to read and express themselves correctly; 3. Patients who have nutritional risks; 4. Informed consent and voluntary participation.

Exclusion criteria

Exclusion criteria: 1. Patients with severe underlying medical conditions; 2. Patients with gastrointestinal dysfunction who are not suitable for enteral nutrition; 3.Patients with severe blood glucose metabolism disorders; 4. Patients with severe liver or kidney insufficiency, among others.

Design outcomes

Primary

MeasureTime frame
Quality of life;

Secondary

MeasureTime frame
Body Mass Index (BMI);Laboratory indicators: PNI (Prognostic Nutritional Index), lymphocytes, alpha-fetoprotein (AFP), serum total protein, albumin, prealbumin, and hemoglobin.;Self-rated depression score.;Nutrition KAP (Knowledge, Attitude, and Practice) score.;Anthropometric indicators: calf circumference, grip strength.;Nutrition score (Patient-Generated Subjective Global Assessment, PGSGA).;The incidence rate of complications;Tumor Regression Grade (TRG);

Countries

China

Contacts

Public ContactLan Zhang

Liaoning Cancer Hospital

18900918211@163.com+86 185 0986 1969

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026